Omkar Pharmachem Share Price | Omkar Pharmachem Stock Screener
OMKARPH
Commodity Chemicals
Share Price BSE
₹27.00
▼
-1.03 (-3.67%)
As of May 14, 2026, the Omkar Pharmachem share price (BSE: OMKARPH) is ₹27.00, down 3.67% from the previous close, with shares trading between ₹27.00 and ₹28.31, and a 52-week range of ₹25.50–₹29.74.
Check OMKARPH 52-week performance for the annual price range and momentum.
Use the Omkar Pharmachem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Omkar Pharmachem Market Cap
₹27.20 Cr.
OMKARPH P/E Ratio (TTM)
337.50
Omkar Pharmachem P/B Ratio
2.86
EPS (TTM)
₹0.20
Dividend Yield
-
Debt to Equity
0.02
OMKARPH 52 Week High
₹29.74
Omkar Pharmachem 52 Week Low
₹25.50
Operating Margin
-
Profit Margin
-
OMKARPH Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹10.00
Total Equity
₹9.00
Omkar Pharmachem Share Price Chart
Screen Omkar Pharmachem share price with an interactive chart. Analyse OMKARPH price trends and volatility across different timeframes.
Omkar Pharmachem Company Profile - Fundamental Screener
Screen Omkar Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for OMKARPH shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE501C01015
Omkar Pharmachem Balance Sheet Screener
Screen OMKARPH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 10 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 |
Omkar Pharmachem Income Statement Screener - Profit & Revenue Analysis
Screen Omkar Pharmachem income statement and profit fundamentals.
Analyze OMKARPH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Omkar Pharmachem share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 54.00% | 52.00% | 58.00% | 50.00% | 8.00% | -454.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.10 | 0.20 | 0.19 | 0.20 | 0.18 | 0.22 | -0.26 | -0.42 | -0.25 | 0.22 | -0.12 | -0.06 |
Omkar Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen OMKARPH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Omkar Pharmachem Shareholding Pattern Screener
See Omkar Pharmachem shareholding pattern with promoter, FII, and DII holdings.
Check Omkar Pharmachem promoter holding and ownership changes for OMKARPH on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% | 98.36% |
| Other Holding | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% | 1.61% |
| Shareholder Count | 3,617 | 3,611 | 3,619 | 3,618 | 3,618 | 3,601 | 3,609 | 3,608 |
Omkar Pharmachem Share Dividend Screener - Share Yield Analysis
Check Omkar Pharmachem dividend history with payout and yield data.
View Omkar Pharmachem dividend details including ex-dates and amounts for OMKARPH stock.
Omkar Pharmachem Stock Index Membership
See which indices include Omkar Pharmachem stock.
Check OMKARPH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Omkar Pharmachem Market Events Screener - Corporate Actions
Get Omkar Pharmachem corporate actions including splits, bonuses, and buybacks.
Check Omkar Pharmachem stock events that may affect OMKARPH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 4.48% | ||
| Annual General Meeting | NA | 0.00% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -6.67% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 4.97% |
Omkar Pharmachem Competitors Screener - Peer Comparison
Screen OMKARPH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 19,513 | -11.14 | 14,584 | -3.49% | -1,631 | 56.22 |
| Deepak Fertilisers & Petrochemicals | 18,387 | 21.21 | 10,355 | 17.69% | 945 | 69.23 |
| Gujarat Narmada Valley Fert & Chem | 7,568 | 9.21 | 7,773 | -7.39% | 753 | 57.92 |
| Gujarat Alkalies & Chemicals | 5,143 | -588.08 | 4,165 | 6.89% | -65 | 50.52 |
| GHCL | 4,075 | 8.66 | 3,064 | -6.33% | 481 | 33.71 |
| TANFAC Industries | 4,065 | 59.87 | 711 | 27.00% | 73 | 32.51 |
| Chemplast Sanmar | 3,856 | -13.01 | 4,393 | 9.61% | -110 | 56.17 |
| Grauer & Weil | 3,088 | 22.09 | 1,180 | 7.28% | 157 | 51.01 |
| Thirumalai Chemicals | 2,543 | -16.32 | 2,070 | -1.54% | -46 | 55.66 |
| Fischer Medical Ventures | 2,444 | 61.03 | 112 | 421.86% | 1 | 54.42 |
Omkar Pharmachem Company Announcements - News Screener
Screen OMKARPH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-25 | Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended On 31St March 2026 | - |
| 2026-05-23 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Change In Name Of Managing Director Of The Company | - |
| 2026-05-14 | Newspaper Publication Regarding Special Window For Transfer And Dematerialization (Demat) Of Physical Shares | - |
| 2026-04-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-03-25 | Newspaper Publication Regarding Special Window For Transfer And Dematerialization (Demat) Of Physical Shares | - |
| 2026-02-16 | Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Unaudited Financial Results For The Quarter And Nine Months Ended On 31.12.2025 | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February 2026 | - |
| 2026-02-12 | Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests From 01St January 2026 To 06Th January 2026 | - |
| 2026-02-04 | Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31.12.2025 | - |
| 2026-01-27 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company. | - |
| 2026-01-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-07 | Announcement Under Regulation 30- Update- Re-Lodgment Of Transfer Of Shares Request Report For The Month Of December 2025 | - |
| 2025-12-29 | Closure of Trading Window | - |
| 2025-12-12 | Re-Lodgment Of Transfer Requests For The Months Of October And November 2025 | - |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-14 | Results- Unaudited Financial Results For September 2025 | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November 2025 | - |